Income Statement

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Abiomed Inc., consolidated income statement

US$ in thousands

12 months ended:	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Revenue	1,031,753)	847,522)	840,883)	769,432)	593,749)	445,304)
Cost of revenue	(188,158)	(161,907)	(151,305)	(129,567)	(98,581)	(70,627)
Gross profit	843,595)	685,615)	689,578)	639,865)	495,168)	374,677)
Research and development	(163,403)	(121,875)	(98,759)	(93,503)	(75,297)	(66,386)
Selling, general and administrative	(423,486)	(334,183)	(341,600)	(321,550)	(262,734)	(218,153)
Acquired in-process research and development	(115,986)	—)	—)	—)	—)	—)
Income from operations	140,720)	229,557)	249,219)	224,812)	157,137)	90,138)
Interest and other income, net	49,840)	58,663)	7,606)	38,548)	3,602)	1,559)
Interest expense	—)	—)	—)	—)	(302)	(354)
Income before income taxes	190,560)	288,220)	256,825)	263,360)	160,437)	91,343)
Income tax provision	(54,055)	(62,695)	(53,816)	(4,344)	(48,267)	(39,227)
Net income	136,505)	225,525)	203,009)	259,016)	112,170)	52,116)

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Download chart

Income statement item	Description	The company
Revenue	Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.	Abiomed Inc. revenue increased from 2020 to 2021 and from 2021 to 2022.
Income from operations	The net result for the period of deducting operating expenses from operating revenues.	Abiomed Inc. income from operations decreased from 2020 to 2021 and from 2021 to 2022.
Income before income taxes	Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.	Abiomed Inc. income before income taxes increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.
Net income	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Abiomed Inc. net income increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.

Abiomed Inc. (NASDAQ:ABMD)

Income Statement